Protein-protein interactions and human cellular cofactors as new targets for HIV therapy

Current Opinion in Pharmacology

Volumn 18, Issue , 2014, Pages 1-8

  Tintori, Cristina ^a   Brai, Annalaura ^a   Fallacara, Anna Lucia ^a,b   Fazi, Roberta ^a   Schenone, Silvia ^c   Botta, Maurizio ^a,d  

^a UNIVERSITY OF SIENA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d Temple University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DDX3 INHIBITOR; GLYCOPROTEIN GP 120; PROTEIN TYROSINE KINASE; PROTEINASE INHIBITOR; REV PROTEIN; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS PROTEIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CCR5 PROTEIN, HUMAN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; DDX3X PROTEIN, HUMAN; DEAD BOX PROTEIN; GP120 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; INTEGRASE; P31 INTEGRASE PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; PSIP1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSCRIPTION FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BINDING SITE; CD4+ T LYMPHOCYTE; DRUG STRUCTURE; ENZYME ACTIVITY; HELPER CELL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RNA BINDING; VIRUS REPLICATION; VIRUS STRAIN; HIV INFECTIONS; HUMAN; METABOLISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTI-HIV AGENTS; ANTIGENS, CD4; DEAD-BOX RNA HELICASES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV INTEGRASE; HUMANS; PROTEIN-TYROSINE KINASES; RECEPTORS, CCR5; TRANSCRIPTION FACTORS;

EID: 84903587511     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2014.06.005     Document Type: Review

References (65)

1. F. Barré-Sinoussi, J.C. Chermann, F. Rey, M.T. Nugeyre, S. Chamaret, J. Gruest, C. Dauguet, C. Axler-Blin, F. Vézinet-Brun, C. Rouzioux, W. Rozenbaum, and L. Montagnier Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) Science 220 1983 868 871
2. Joint United Nations Programme on HIV/AIDS (UNAIDS), report on the global AIDS epidemic 2013.
3. M.P. Girard, S. Osmanov, O.M. Assossou, and M.P. Kieny Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review Vaccine 29 2011 6191 6218
4. G. Antonelli, and O. Turriziani Antiviral therapy: old and current issues Int J Antimicrob Agents 40 2012 95 102
5. M. Mori, F. Manetti, and M. Botta Targeting protein-protein and protein-nucleic acid interactions for anti-HIV therapy Curr Pharm Des 17 2011 3713 3728
6. C. Ottman A. Dömling, Protein-Protein Interactions: An Overview, in Protein-Protein Interactions in Drug Discovery 2013 Wiley-VCH Verlag GmbH & Co. KGaA Weinheim, Germany
7. F. Christ, and Z. Debyser The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy Virology 435 2013 102 109
8. D.G. Myszka, R.W. Sweet, P. Hensley, M. Brigham-Burke, P.D. Kwong, W.A. Hendrickson, R. Wyatt, J. Sodroski, and M.L. Doyle Energetics of the HIV gp120-CD4 binding reaction Proc Natl Acad Sci U S A 97 2000 9026 9031 (Pubitemid 30626667)
9. R. Wyatt, and J. Sodroski The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens Science 280 1998 1884 1888 (Pubitemid 28299385)
10. P.D. Kwong, R. Wyatt, J. Robinson, R.W. Sweet, J. Sodroski, and W.A. Hendrickson Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody Nature 393 1998 648 659 (Pubitemid 28289647)
11. Q. Zhao, L. Ma, S. Jiang, H. Lu, S. Liu, Y. He, N. Strick, N. Neamati, and A.K. Debnath Identification of N-phenyl-N′-(2,2,6,6-tetramethyl- piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4 Virology 339 2005 213 225 (Pubitemid 41169789)
12. N. Madani, A. Schon, A.M. Princiotto, J.M. Lalonde, J.R. Courter, T. Soeta, D. Ng, L. Wang, E.T. Brower, S.H. Xiang, Y.D. Kwon, C.C. Huang, R. Wyatt, P.D. Kwong, E. Freire, A.B. Smith 3rd, and J. Sodroski Small-molecule CD4 mimics interact with a highly conserved pocket on HIV-1 gp120 Structure 16 2008 1689 1701
13. F. Curreli, S. Choudhury, I. Pyatkin, V.P. Zagorodnikov, A.K. Bulay, A. Altieri, Y.D. Kwon, P.D. Kwong, and A.K. Debnath Design, synthesis, and antiviral activity of entry inhibitors that target the CD4-binding site of HIV-1 J Med Chem 55 2012 4764 4775
14. J.M. Lalonde, M.A. Elban, J.R. Courter, A. Sugawara, T. Soeta, N. Madani, A.M. Princiotto, Y.D. Kwon, P.D. Kwong, A. Schon, E. Freire, J. Sodroski, and A.B. Smith 3rd Design, synthesis and biological evaluation of small molecule inhibitors of CD4-gp120 binding based on virtual screening Bioorg Med Chem 19 2011 91 101
15. J.M. LaLonde, Y.D. Kwon, D.M. Jones, A.W. Sun, J.R. Courter, T. Soeta, T. Kobayashi, A.M. Princiotto, X. Wu, A. Schon, E. Freire, P.D. Kwong, J.R. Mascola, J. Sodroski, N. Madani, and A.B. Smith 3rd Structure-based design, synthesis, and characterization of dual hotspot small-molecule HIV-1 entry inhibitors J Med Chem 55 2012 4382 4396
16. J.M. Lalonde, M. Le-Khac, D.M. Jones, J.R. Courter, J. Park, A. Schon, A.M. Princiotto, X. Wu, J.R. Mascola, E. Freire, J. Sodroski, N. Madani, W.A. Hendrickson, and A.B. Smith 3rd Structure-based design and synthesis of an HIV-1 entry inhibitor exploiting X-ray and thermodynamic characterization ACS Med Chem Lett 4 2013 338 343
17. Y.D. Kwon, A. Finzi, X. Wu, C. Dogo-Isonagie, L.K. Lee, L.R. Moore, S.D. Schmidt, J. Stuckey, Y. Yang, T. Zhou, J. Zhu, D.A. Vicic, A.K. Debnath, L. Shapiro, C.A. Bewley, J.R. Mascola, J.G. Sodroski, and P.D. Kwong Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops Proc Natl Acad Sci U S A 109 2012 5663 5668
18. A.K. Debnath Rational design of HIV-1 entry inhibitors Methods Mol Biol 993 2013 185 204
19. C. Tintori, M. Selvaraj, R. Badia, B. Clotet, J.A. Este, and M. Botta Computational studies identifying entry inhibitor scaffolds targeting the Phe43 cavity of HIV-1 gp120 ChemMedChem 8 2013 475 483
20. M. Tiberi, C. Tintori, E.R. Ceresola, R. Fazi, C. Zamperini, P. Calandro, L. Franchi, M. Selvaraj, L. Botta, M. Sampaolo, D. Saita, R. Ferrarese, M. Clementi, F. Canducci, and M. Botta 2-aminothiazolones as anti-HIV agents which act as gp120-CD4 inhibitors Antimicrob Agents Chemother 2014 10.1128/AAC.02739-13
21. E. Guiot, K. Carayon, O. Delelis, F. Simon, P. Tauc, E. Zubin, M. Gottikh, J.F. Mouscadet, J.C. Brochon, and E. Deprez Relationship between the oligomeric status of HIV-1 integrase on DNA and enzymatic activity J Biol Chem 281 2006 22707 22719
22. R.G. Maroun, S. Gayet, M.S. Benleulmi, H. Porumb, L. Zargarian, H. Merad, H. Leh, J.F. Mouscadet, F. Troalen, and S. Fermandjian Peptide inhibitors of HIV-1 integrase dissociate the enzyme oligomers Biochemistry 40 2001 13840 13848 (Pubitemid 33078852)
23. L. Zhao, M.K. O'Reilly, M.D. Shultz, and J. Chmielewski Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization Bioorg Med Chem Lett 13 2003 1175 1177 (Pubitemid 36331825)
24. L. Zhao, and J. Chmielewski Inhibition of HIV-1 integrase dimerization and activity with crosslinked interfacial peptides Bioorg Med Chem 21 2013 4041 4044
25. C. Tintori, J. Demeulemeester, L. Franchi, S. Massa, Z. Debyser, F. Christ, and M. Botta Discovery of small molecule HIV-1 integrase dimerization inhibitors Bioorg Med Chem Lett 22 2012 3109 3114
26. J. Demeulemeester, C. Tintori, M. Botta, Z. Debyser, and F. Christ Development of an AlphaScreen-based HIV-1 integrase dimerization assay for discovery of novel allosteric inhibitors J Biomol Screen 17 2012 618 628
27. M.E. Linde, D.R. Colquhoun, C. Ubaida Mohien, T. Kole, V. Aquino, R. Cotter, N. Edwards, J.E. Hildreth, and D.R. Graham The conserved set of host proteins incorporated into HIV-1 virions suggests a common egress pathway in multiple cell types J Proteome Res 12 2013 2045 2054
28. N. Arhel, and F. Kirchhoff Host proteins involved in HIV infection: new therapeutic targets Biochim Biophys Acta 1802 2010 313 321
29. H. Fadel, and Z. Temesgen Maraviroc Drugs Today (Barc) 43 2007 749 758
30. P.E. Sax FDA approval: maraviroc AIDS Clin Care 19 2007 75
31. R. Dürr, O. Keppler, F. Christ, E. Crespan, A. Garbelli, G. Maga, and U. Dietrich Targeting cellular cofactor in HIV therapy Top Med Chem 2014 1 40 10.1007/7355-2014-45
32. G. Hassaine, M. Courcoul, G. Bessou, Y. Barthalay, C. Picard, D. Olive, Y. Collette, R. Vigne, and E. Decroly Tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral Vif protein J Biol Chem 276 2001 16885 16893
33. J. Jung, I.J. Bugault, and A.M. Gronenborn Structure, dynamics and Hck interaction of full-length HIV-1 Nef Protein 79 2011 1609 1622
34. T. Pene-Dumitrescu, S.T. Shu, T.E. Wales, J.J. Alvarado, H. Shi, P. Narute, J.A. Moroco, J.I. Yeh, J.R. Engen, and T.E. Smithgall HIV-1 Nef interaction influences the ATP-binding site of the Src-family kinase, Hck BMC Chem Biol 12 2012 1
35. S.D. Briggs, M. Sharkey, M. Stevenson, and T.E. Smithgall SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein HIV-1 J Biol Chem 272 1997 17899 178902
36. E.C. Lerner, and T.E. Smithgall SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo Nat Struct Biol 9 2002 365 369 (Pubitemid 34462555)
37. H.J. Choi, and T.E. Smithgall Conserved residues in the HIV-1 Nef hydrophobic pocket are essential for recruitment and activation of Hck tyrosine kinase J Mol Biol 343 2004 1255 1268 (Pubitemid 39387825)
38. R.P. Trible, L. Emert-Sedlak, and T.E. Smithgall HIV-1 Nef selectively activates Src family kinases Hck, Lyn and c-Src through direct SH3 domain interaction J Biol Chem 281 2006 27029 27038 (Pubitemid 44401731)
39. C. Tintori, I. Laurenzana, F. La Rocca, F. Falchi, F. Carraro, A. Ruiz, J.A. Esté, M. Kissova, E. Crespan, G. Maga, M. Biava, C. Brullo, S. Schenone, and M. Botta Identification of Hck inhibitors as hits for the development of antileukemia and anti-HIV agents Chem Med Chem 8 2013 1353 1360
40. L. Emert-Sedlak, T. Kodama, E.C. Lerner, W. Dai, C. Foster, B.W. Day, J.S. Lazo, and T.E. Smithgall Chemical library screens targeting an HIV-1 accessory factor/host cell kinase complex identify novel antiretroviral compounds ACS Chem Biol 4 2009 939 947
41. A.B. Strasner, M. Natarajan, T. Doman, D. Key, A. August, and A.J. Henderson The Src kinase Lck facilitates assembly of HIV-1 at the plasma membrane J Immunol 181 2008 3706 3713
42. M.I. Toulouze, N. Sol-Foulon, F. Blanchet, A. Dautry-Varsat, O. Shwartz, and A. Alcover Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse Immunity 24 2006 547 561 (Pubitemid 43728159)
43. M. Douaisi, S. Dussart, M. Courcoul, G. Bessou, E.C. Lerner, E. Decroly, and R. Vogne The tyrosine kinases Fyn and Hck favor the recruitment of tyrosine-phosphorylated APOBEC3G into Vif-defective HIV-1 particles Biochem Biophys Res Commun 329 2005 917 924 (Pubitemid 40341364)
44. B. Harmon, N. Campbell, and L. Ratner Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step PLoS Pathog 6 2010 e1000956
45. M.L. Garron, J. Arthos, J.F. Guichou, J. McNally, J. Cicala, and S.T. Arold Structural basis for the interaction between focal adhesion kinase and CD4 J Mol Biol 375 2008 1320 1328
46. J.A. Readinger, G.M. Schiralli, J.K. Jiang, C.J. Thomas, A. August, A.J. Henderson, and P.L. Schwartzberg Selective targeting of ITK blocks multiple steps of HIV replication Proc Natl Acad Sci U S A 105 2008 6684 6689 (Pubitemid 351754567)
47. A. Klatt, Z. Zhang, P. Kalantari, P.A. Hankey, D.S. Gilmour, and A.J. Henderson The receptor tyrosine kinase RON represses HIV-1 transcription by targeting RNA polymerase II processivity J Immunol 180 2008 1670 1677
48. E.S. Lee, P. Kalantari, S. Tsutsui Section, A. Klatt, J. Holden, P.H. Correl, C. Power Section, and A.J. Henderson RON receptor tyrosine kinase, a negative regulator of inflammation, inhibits HIV-1 transcription in monocytes/macrophages and is decreased in brain tissue from patients with AIDS J Immunol 173 2004 6864 6872 (Pubitemid 39541073)
49. S. Mitola, S. Sozzani, W. Luini, L. Primo, A. Borsatti, H. Weich, and F. Bussolino Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1 Blood 90 1997 1365 1372 (Pubitemid 27355407)
50. E. Mouhayar, J.B. Durand, and J. Cortes Cardiovascular toxicity of tyrosine kinase inhibitors Expert Opin Drug Saf 12 2013 687 696
51. G.S. Orphanos, G.N. Ioannidis, and A.G. Ardavanis Cardiotoxicity induced by tyrosine kinase inhibitors Acta Oncol 48 2009 964 970
52. S.W. Cowan-Jacob, W. Jahnke, and S. Knapp Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases Future Med Chem 6 2014 541 561
53. S.H. Park, S.G. Lee, Y. Kim, and K. Song Assignment of a human putative RNA helicase gene, DDX3, to human X chromosome bands p11.3→p11.23 Cytogenet Cell Genet 81 1998 178 179 (Pubitemid 28431933)
54. V.S. Yedavalli, C. Neuveut, Y.H. Chi, L. Kleiman, and K.T. Jeang Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function Cell 119 2004 381 392 (Pubitemid 39423840)
55. A. Garbelli, M. Radi, F. Falchi, S. Beermann, S. Zanoli, F. Manetti, U. Dietrich, M. Botta, and G. Maga Targeting the human DEAD-box polypeptide 3 (DDX3) RNA helicase as a novel strategy to inhibit viral replication Curr Med Chem 18 2011 3015 3027
56. M. Ishaq, J. Hu, X. Wu, Q. Fu, Y. Yang, Q. Liu, and D. Guo Knockdown of cellular RNA helicase DDX3 by short hairpin RNAs suppresses HIV-1 viral replication without inducing apoptosis Mol Biotechnol 39 2008 231 238
57. C.S. Lee, A.P. Dias, M. Jedrychowski, A.H. Patel, J.L. Hsu, and R. Reed Human DDX3 functions in translation and interacts with the translation initiation factor eIF3 Nucleic Acids Res 36 2008 4708 4718
58. G. Maga, F. Falchi, M. Radi, L. Botta, G. Casaluce, M. Bernardini, H. Irannejad, F. Manetti, A. Garbelli, A. Samuele, S. Zanoli, J.A. Esté, E. Gonzalez, E. Zucca, S. Paolucci, F. Baldanti, J. De Rijck, Z. Debyser, and M. Botta Toward the discovery of novel anti-HIV drugs. Second-generation inhibitors of the cellular ATPase DDX3 with improved anti-HIV activity: synthesis, structure-activity relationship analysis, cytotoxicity studies, and target validation ChemMedChem 6 2011 1371 1389
59. O. Cordin, J. Banroques, N.K. Tanner, and P. Linder The DEAD-box protein family of RNA helicases Gene 367 2006 17 37 (Pubitemid 43286737)
60. G. Maga, F. Falchi, A. Garbelli, A. Belfiore, M. Witvrouw, F. Manetti, and M. Botta Pharmacophore modeling and molecular docking led to the discovery of inhibitors of human immunodeficiency virus-1 replication targeting the human cellular aspartic acid-glutamic acid-alanine-aspartic acid box polypeptide 3 J Med Chem 51 2008 6635 6638
61. V.S. Yedavalli, N. Zhang, H. Cai, P. Zhang, M.F. Starost, R.S. Hosmane, and K.T. Jeang Ring expanded nucleoside analogues inhibit RNA helicase and intracellular human immunodeficiency virus type 1 replication J Med Chem 51 2008 5043 5051
62. P. Schütz, T. Karlberg, S. van den Berg, R. Collins, L. Lehtiö, M. Högbom, L. Holmberg-Schiavone, W. Tempel, H.W. Park, M. Hammarström, M. Moche, A.G. Thorsell, and H. Schüler Comparative structural analysis of human DEAD-box RNA helicases PLoS ONE 5 2010 e12791
63. T. Sekiguchi, Y. Kurihara, and J. Fukumura Phosphorylation of threonine 204 of DEAD-box RNA helicase DDX3 by cyclin B/cdc2 in vitro Biochem Biophys Res Commun 356 2007 668 673 (Pubitemid 46499016)
64. Radi M, Botta M, Maga G, Falchi F, Baldanti F, Paolucci S. Compounds with DDX3 inhibitory activity and uses thereof. WO/2011/039735.
65. M. Radi, F. Falchi, A. Garbelli, A. Samuele, V. Bernardo, S. Paolucci, F. Baldanti, S. Schenone, F. Manetti, G. Maga, and M. Botta Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: towards the next generation HIV-1 inhibitors Bioorg Med Chem Lett 22 2012 2094 2098